Joseph McKendrick

3.9k total citations · 1 hit paper
57 papers, 1.4k citations indexed

About

Joseph McKendrick is a scholar working on Oncology, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, Joseph McKendrick has authored 57 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Oncology, 13 papers in Surgery and 12 papers in Pathology and Forensic Medicine. Recurrent topics in Joseph McKendrick's work include Colorectal Cancer Treatments and Studies (28 papers), Colorectal Cancer Surgical Treatments (12 papers) and Colorectal and Anal Carcinomas (10 papers). Joseph McKendrick is often cited by papers focused on Colorectal Cancer Treatments and Studies (28 papers), Colorectal Cancer Surgical Treatments (12 papers) and Colorectal and Anal Carcinomas (10 papers). Joseph McKendrick collaborates with scholars based in Australia, United Kingdom and United States. Joseph McKendrick's co-authors include John Mackay, Trevor Leong, Samuel Y. Ngan, Richard Fisher, Bryan Burmeister, Stephen P. Ackland, John Zalcberg, Michael J. Solomon, Bev McClure and David Goldstein and has published in prestigious journals such as Nature, Journal of Clinical Oncology and Blood.

In The Last Decade

Joseph McKendrick

56 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Randomized Trial of Short-Course Radiotherapy Versus Long-Course Chemoradiation Comparing Rates of Local Recurrence in Patients With T3 Rectal Cancer: Trans-Tasman Radiation Oncology Group Trial 01.04

2012 585 citations Samuel Y. Ngan, Bryan Burmeister et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Joseph McKendrick

Since Specialization

Citations

This map shows the geographic impact of Joseph McKendrick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph McKendrick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph McKendrick more than expected).

Fields of papers citing papers by Joseph McKendrick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph McKendrick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph McKendrick. The network helps show where Joseph McKendrick may publish in the future.

Co-authorship network of co-authors of Joseph McKendrick

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph McKendrick. A scholar is included among the top collaborators of Joseph McKendrick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph McKendrick. Joseph McKendrick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Heterozygous germline TET2 loss‐of‐function variants associated with an ALPS ‐like phenotype 2025 ·British Journal of Haematology ·(unknown), Joshua Casan, Hannah Rose, Michael Sullivan, Sam Mehr, (unknown), (unknown), Joseph McKendrick, Mary Ann Anderson, Nicole den Elzen, (unknown), Lucy C. Fox, Stephen Lade, Piers Blombery	0
2	Immune priming with avelumab and rituximab prior to R-CHOP in diffuse large B-cell lymphoma: the phase II AvR-CHOP study 2023 ·Leukemia ·(unknown), Geoffrey Chong, Colm Keane, Sze-Ting Lee, Charmaine Smith, Leonid Churilov, Joseph McKendrick, William Renwick, Piers Blombery, Melinda Burgess, (unknown), (unknown), (unknown), (unknown), Andrew M. Scott, Allison Barraclough, Joel Wight, Andrew Grigg, Chun Yew Fong, Eliza A. Hawkes	11
3	Results of phase II trial of intensified neoadjuvant treatment with interdigitating radiotherapy and chemotherapy with oxaliplatin, 5-fluorouracil and folinic acid in patients with locally advanced rectal cancer (PROARCT trial) 2020 ·Radiotherapy and Oncology ·Sweet Ping Ng, Julie Chu, Sarat Chander, Mathias Bressel, Joseph McKendrick, Rachel Wong, Malcolm Steel, William K. Murray, Trevor Leong, Alexander G. Heriot, Michael Michael, Samuel Y. Ngan	6
4	Safety and Efficacy of Induction and Maintenance Avelumab Plus R-CHOP in Patients with Diffuse Large B-Cell Lymphoma (DLBCL): Analysis of the Phase II Avr-CHOP Study 2020 ·Blood ·Eliza A. Hawkes, Geoffrey Chong, Charmaine Smith, Sze-Ting Lee, Leonid Churilov, Joseph McKendrick, William Renwick, Piers Blombery, (unknown), (unknown), (unknown), (unknown), Andrew M. Scott, Allison Barraclough, Joel Wight, Andrew Grigg, Colm Keane, Chun Yew Fong, (unknown)	10
5	Exploring the spectrum of late effects following radical orchidectomy for stage I testicular seminoma: a systematic review of the literature 2018 ·Supportive Care in Cancer ·(unknown), A. Antón, J. Torres-Borrego, Ruth M. Lawrence, Phillip Parente, Joseph McKendrick, Ian D. Davis, Carmel Pezaro	4
6	Treatment sequencing and outcomes in synchronous metastatic rectal cancer. 2017 ·Journal of Clinical Oncology ·(unknown), Margaret Lee, Anna J. Lomax, Michael Ng, Mario Guerrieri, Thiru Prasanna, Hui‐Li Wong, Belinda Lee, Joseph McKendrick, Lionel Lim, Suzanne Kosmider, Jeanne Tie, Desmond Yip, Louise Nott, (unknown), (unknown), Peter Gibbs, Rachel Wong	1
7	The impact on health-related quality of life in the first 12 months: A randomised comparison of preoperative short-course radiation versus long-course chemoradiation for T3 rectal cancer (Trans-Tasman Radiation Oncology Group Trial 01.04) 2016 ·European Journal of Cancer ·Sue-Anne McLachlan, Richard Fisher, John Zalcberg, Michael J. Solomon, Bryan Burmeister, David Goldstein, Trevor Leong, Stephen P. Ackland, Joseph McKendrick, Bev McClure, John Mackay, Samuel Y. Ngan	40
8	Survival Impact of Adjuvant Chemotherapy for Resected Locally Advanced Rectal Adenocarcinoma 2016 ·Clinical Colorectal Cancer ·Rebecca Tay, (unknown), Malcolm Steel, Hui‐Li Wong, Joseph McKendrick, Ian Faragher, Suzanne Kosmider, (unknown), Jayesh Desai, Mark Tacey, Peter Gibbs, Rachel Wong	9
9	Posterior reversible encephalopathy syndrome mimicking brain metastases in a patient with metastatic transitional cell carcinoma 2016 ·Asia-Pacific Journal of Clinical Oncology ·(unknown), Margaret Lee, Ian D. Davis, Phillip Parente, Joseph McKendrick, Carmel Pezaro	1
10	Time course of safety and efficacy of aflibercept in combination with FOLFIRI in patients with metastatic colorectal cancer who progressed on previous oxaliplatin-based therapy 2014 ·European Journal of Cancer ·Paul Ruff, David Ferry, Radek Lakomý, Jana Prausová, Guy A. Van Hazel, Paulo M. Hoff, David Cunningham, Dirk Arnold, Hans‐Joachim Schmoll, Vladimir Moiseyenko, Joseph McKendrick, Albert J. ten Tije, (unknown), Pankaj Bhargava, Soazig Chevalier, Teresa Macarulla, Eric Van Cutsem	20
11	Aflibercept versus placebo in combination with fluorouracil, leucovorin and irinotecan in the treatment of previously treated metastatic colorectal cancer: Prespecified subgroup analyses from the VELOUR trial 2013 ·European Journal of Cancer ·Josep Tabernero, Eric Van Cutsem, Radek Lakomý, Jana Prausová, Paul Ruff, Guy A. Van Hazel, Vladimir Moiseyenko, David Ferry, Joseph McKendrick, Karen Soussan-Lazard, Soazig Chevalier, Carmen J. Allegra	159
12	Massively parallel sequencing (MPS) of circulating DNA in patients with metastatic colorectal cancer (mCRC): Prognostic significance and early changes during chemotherapy (CT). 2013 ·Journal of Clinical Oncology ·Jeanne Tie, Isaac Kinde, Hui‐Li Wong, Joseph McKendrick, Peter Gibbs, Madhu Singh, Christos S. Karapetis, Jayesh Desai, Ben Tran, (unknown), Kenneth W. Kinzler, Bert Vogelstein	1
13	Randomized Trial of Short-Course Radiotherapy Versus Long-Course Chemoradiation Comparing Rates of Local Recurrence in Patients With T3 Rectal Cancer: Trans-Tasman Radiation Oncology Group Trial 01.04 breakdown → 2012 ·Journal of Clinical Oncology ·Samuel Y. Ngan, Bryan Burmeister, Richard Fisher, Michael J. Solomon, David Goldstein, David Joseph, Stephen P. Ackland, David Schache, Bev McClure, Sue‐Anne McLachlan, Joseph McKendrick, Trevor Leong, (unknown), John Zalcberg, John Mackay	585
14	Capecitabine: effective oral fluoropyrimidine chemotherapy 2005 ·Expert Opinion on Pharmacotherapy ·Joseph McKendrick, John Coutsouvelis	21
15	Capecitabine plus docetaxel combination therapy 2005 ·Cancer ·Shailendra Verma, D Maraninchi, Joyce O’Shaughnessy, Carol Jamieson, Stephen E. Jones, Miguel Martín, Joseph McKendrick, David Miles, Chris Twelves, John Hornberger	18
16	Promising Results of a Cooperative Group Phase II Trial of Preoperative Chemoradiation for Locally Advanced Rectal Cancer (TROG 9801) 2005 ·Diseases of the Colon & Rectum ·Samuel Y. Ngan, Richard Fisher, Bryan Burmeister, John Mackay, David Goldstein, Andrew Kneebone, David Schache, David Joseph, Joseph McKendrick, Trevor Leong, (unknown), Danny Rischin	15
17	The Granzyme B Inhibitor, PI-9, Is Present in Endothelial and Mesothelial Cells, Suggesting That It Protects Bystander Cells during Immune Responses 2001 ·Cellular Immunology ·Marguerite S. Buzza, Claire E. Hirst, Catherina H. Bird, Patrick Hosking, Joseph McKendrick, Phillip I. Bird	73
18	A Phase I and Pharmacokinetic Study of Subcutaneously-Administered Recombinant Human Interleukin-4 (rhuIL-4) in Patients with Advanced Cancer 2000 ·Growth Factors ·Ian D. Davis, (unknown), Jonathan Cebon, Michael D. Green, Richard M. Fox, Joseph McKendrick, Mary Ellen Rybak, Andy Boyd	3
19	CHORIOCARCINOMA OF THE URINARY BLADDER 1999 ·Australian and New Zealand Journal of Surgery ·(unknown), Joseph McKendrick	7
20	Dose Escalation Study of Carboplatin and Cyclophosphamide With Filgrastim Support 1998 ·American Journal of Clinical Oncology ·Guy C. Toner, Michael D. Green, James F. Bishop, Joseph McKendrick, Jonathan Cebon, William Sheridan, Pamela Lockbaum, J O’Byrne, Richard M. Fox	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact